🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this clinical study is to compare the safety and efficacy ...
Status
Completed
Location
Bausch & Lomb, Incorporated
Start Date
2010-11
Trial ID
NCT01230125
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of three ...
Status
Completed
Location
PAREXEL International (Bloemfontein)
Start Date
2009-07-15
Trial ID
NCT00944632
Treatments Being Tested
This clinical study is being conducted to identify the most effective drug ...
Status
Completed
Location
Bausch & Lomb
Start Date
2009-06
Trial ID
NCT00905450
Treatments Being Tested
The objective of this study is to compare the safety and efficacy of Maprac...
Status
Terminated
Location
Bausch & Lomb Incorporated
Start Date
2011-02
Trial ID
NCT01298752
Treatments Being Tested
The objective of this clinical study is to compare the safety and efficacy ...
Status
Completed
Location
Bausch & Lomb, Incorporated
Start Date
2012-07
Trial ID
NCT01591655
Treatments Being Tested
Evaluation of efficacy and safety of Mapracorat 0.1% ointment and 4 compara...
Status
Completed
Location
Multiple Locations
Start Date
2013-02-11
Trial ID
NCT03399526
A multicenter, open-label study to evaluate the adrenal suppression potenti...
Status
Completed
Location
Kawaguchi Kogyo General Hospital
Start Date
2011-05-09
Trial ID
NCT01407510
Treatments Being Tested
The objective of this study is to evaluate the effect on corneal endothelia...
Status
Completed
Location
Bausch & Lomb Inc
Start Date
2013-02
Trial ID
NCT01736462
Treatments Being Tested
The objective of this clinical study is to compare the safety and efficacy ...
Status
Completed
Location
Bausch & Lomb Incorporated
Start Date
2012-07
Trial ID
NCT01591161
Treatments Being Tested
The objective of this study is to evaluate the dose response, and efficacy ...
Status
Completed
Location
Bausch & Lomb
Start Date
2011-02
Trial ID
NCT01289431
Treatments Being Tested